Page last updated: 2024-08-21

isoxazoles and Carcinoma, Basal Cell

isoxazoles has been researched along with Carcinoma, Basal Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alfonsi, R; Brunetti, M; Colaceci, F; Di Marcotullio, L; Filocamo, G; Lahm, A; Mancuso, M; Pasquali, E; Pazzaglia, S; Saran, A; Sasso, R; Steinkühler, C; Tanori, M	1

Other Studies

1 other study(ies) available for isoxazoles and Carcinoma, Basal Cell

Article	Year
MK-4101, a Potent Inhibitor of the Hedgehog Pathway, Is Highly Active against Medulloblastoma and Basal Cell Carcinoma. Molecular cancer therapeutics, 2016, Volume: 15, Issue:6 Topics: Animals; Antineoplastic Agents; Carcinoma, Basal Cell; Cell Cycle; Cell Proliferation; Cell Survival; Cerebellar Neoplasms; Hedgehog Proteins; Humans; Isoxazoles; Medulloblastoma; Mice; Neoplasm Transplantation; Random Allocation; Signal Transduction; Triazoles; Xenograft Model Antitumor Assays	2016

Article

Year

MK-4101, a Potent Inhibitor of the Hedgehog Pathway, Is Highly Active against Medulloblastoma and Basal Cell Carcinoma.

Molecular cancer therapeutics, 2016, Volume: 15, Issue:6

Topics: Animals; Antineoplastic Agents; Carcinoma, Basal Cell; Cell Cycle; Cell Proliferation; Cell Survival; Cerebellar Neoplasms; Hedgehog Proteins; Humans; Isoxazoles; Medulloblastoma; Mice; Neoplasm Transplantation; Random Allocation; Signal Transduction; Triazoles; Xenograft Model Antitumor Assays

2016